RIL
Rothschild Investment LLC Portfolio holdings
AUM
$1.6B
1-Year Return
17.99%
This Quarter Return
+9.71%
1 Year Return
+17.99%
3 Year Return
+73.94%
5 Year Return
+135.61%
10 Year Return
+254.21%
AUM
$1.6B
AUM Growth
+$101M
(+6.8%)
Cap. Flow
-$4.27M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
23.06%
Holding
3,233
New
209
Increased
1,380
Reduced
863
Closed
217
Top Buys
Top Sells
| 1 |
Novo Nordisk
NVO
|
+$7.27M |
| 2 |
Kenvue
KVUE
|
+$4.89M |
| 3 |
FPF
First Trust Intermediate Duration Preferred & Income Fund
FPF
|
+$3.13M |
| 4 |
Nuveen Preferred & Income Opportunities Fund
JPC
|
+$2.87M |
| 5 |
Apple
AAPL
|
+$2.73M |
Sector Composition
| 1 | Technology | 18.15% |
| 2 | Financials | 13.7% |
| 3 | Industrials | 9.06% |
| 4 | Healthcare | 7.79% |
| 5 | Communication Services | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Metropolitan Bank Holding Corp
MCB
$807M
| $2.1K | ﹤0.01% |
30
+5
| +20% | +$350 |
|
2027
Edgewise Therapeutics
EWTX
$1.5B
| $2.1K | ﹤0.01% |
160
+40
| +33% | +$525 |
|
2028
Hanmi Financial
HAFC
$748M
| $2.1K | ﹤0.01% |
85
+20
| +31% | +$494 |
|
2029
Spirit AeroSystems
SPR
$4.54B
| $2.1K | ﹤0.01% |
55
+15
| +38% | +$572 |
|
2030
Spyre Therapeutics
SYRE
$945M
| $2.1K | ﹤0.01% |
140
+90
| +180% | +$1.35K |
|
2031
CorMedix
CRMD
$966M
| $2.09K | ﹤0.01% |
170
+50
| +42% | +$616 |
|
2032
Premier
PINC
$2.2B
| $2.08K | ﹤0.01% |
+95
| New | +$2.08K |
|
2033
BrightView Holdings
BV
$1.32B
| $2.08K | ﹤0.01% |
125
+65
| +108% | +$1.08K |
|
|
RWT
2034
Redwood Trust
RWT
$804M
| $2.08K | ﹤0.01% |
352
+150
| +74% | +$886 |
|
2035
Novavax
NVAX
$1.3B
| $2.08K | ﹤0.01% |
330
+100
| +43% | +$630 |
|
2036
Quanex
NX
$661M
| $2.08K | ﹤0.01% |
110
-50
| -31% | -$945 |
|
2037
Kulicke & Soffa
KLIC
$2.01B
| $2.08K | ﹤0.01% |
60
-5
| -8% | -$173 |
|
2038
Akamai
AKAM
$11B
| $2.07K | ﹤0.01% |
26
-1
| -4% | -$80 |
|
2039
Enhabit
EHAB
$399M
| $2.07K | ﹤0.01% |
215
| – | – |
|
2040
Shoals Technologies Group
SHLS
$1.15B
| $2.06K | ﹤0.01% |
485
+230
| +90% | +$977 |
|
2041
MRC Global
MRC
$1.23B
| $2.06K | ﹤0.01% |
150
+15
| +11% | +$206 |
|
2042
InvenTrust Properties
IVT
$2.33B
| $2.06K | ﹤0.01% |
75
-45
| -38% | -$1.23K |
|
2043
Hamilton Insurance Group
HG
$2.42B
| $2.05K | ﹤0.01% |
95
+25
| +36% | +$541 |
|
2044
Sylvamo
SLVM
$1.75B
| $2.05K | ﹤0.01% |
41
-30
| -42% | -$1.5K |
|
2045
Sonos
SONO
$1.83B
| $2.05K | ﹤0.01% |
190
+50
| +36% | +$541 |
|
2046
PubMatic
PUBM
$376M
| $2.05K | ﹤0.01% |
165
+125
| +313% | +$1.56K |
|
2047
OneMain Financial
OMF
$7.2B
| $2.05K | ﹤0.01% |
36
+11
| +44% | +$627 |
|
2048
Ryerson Holding
RYI
$723M
| $2.05K | ﹤0.01% |
95
+10
| +12% | +$216 |
|
2049
Supernus Pharmaceuticals
SUPN
$2.55B
| $2.05K | ﹤0.01% |
65
+25
| +63% | +$788 |
|
2050
Beam Therapeutics
BEAM
$2.08B
| $2.04K | ﹤0.01% |
120
-30
| -20% | -$510 |
|